A share price of Haemonetics Corp [HAE] is currently trading at $78.17, up 0.84%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HAE shares have gain 2.53% over the last week, with a monthly amount glided 9.10%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Haemonetics Corp [NYSE: HAE] stock has seen the most recent analyst activity on July 09, 2025, when Citigroup upgraded its rating to a Buy but kept the price target unchanged to $90 for it. Previously, Robert W. Baird started tracking the stock with Outperform rating on June 26, 2025, and set its price target to $87. On February 07, 2025, downgrade downgraded it’s rating to Underperform and revised its price target to $68 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $116 on December 06, 2024. Raymond James upgraded its rating to a Strong Buy but $120 remained the price target by the analyst firm on November 08, 2024. CL King started tracking with a Buy rating for this stock on September 13, 2024, and assigned it a price target of $116. In a note dated September 11, 2024, BofA Securities initiated an Neutral rating and provided a target price of $85 on this stock.
Haemonetics Corp experienced fluctuations in its stock price throughout the past year between $55.30 and $94.99. Currently, Wall Street analysts expect the stock to reach $108.25 within the next 12 months. Haemonetics Corp [NYSE: HAE] shares were valued at $78.17 at the most recent close of the market. An investor can expect a potential return of 38.48% based on the average HAE price forecast.
Analyzing the HAE fundamentals
Trailing Twelve Months sales for Haemonetics Corp [NYSE:HAE] were 1.36B which represents -3.70% decline. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.18 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 77.25 points at the first support level, and at 76.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 79.37, and for the 2nd resistance point, it is at 80.57.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Haemonetics Corp [NYSE:HAE] is 1.62. In addition, the Quick Ratio stands at 0.99 and the Cash Ratio stands at 0.53. Considering the valuation of this stock, the price to sales ratio is 2.76, the price to book ratio is 4.59 and price to earnings (TTM) ratio is 23.57.
Transactions by insiders
Recent insider trading involved Llorens Josep, Former Officer, that happened on Jun 26 ’25 when 18630.0 shares were purchased. Former Officer, Strong Stewart W completed a deal on Jun 12 ’25 to buy 708.0 shares. Meanwhile, Officer Strong Stewart W bought 7705.0 shares on Jun 04 ’25.
